While POMC deficiency is very rare, 1–5% of severely obese individuals harbor heterozygous mutations in MC4R. We sought to assess the efficacy of Setmelanotide in human MC4R deficiency. This evidence concerns the gene MC4R and hyperinsulinemic hypoglycemia, familial, 4.